Dynavax Technologies Corporation (DVAX)

Add to Watchlists Create an Alert
2.55 +0.02  +0.79%   NASDAQ May 24, 5:00PM BATS Real time Currency in USD

Dynavax Technologies Corporation Return on Equity:

-64.48% for Dec. 31, 2012
View Full Chart

Dynavax Technologies Corporation Return on Equity Chart

    Dynavax Technologies Corporation Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -64.48%
    Dec. 31, 2012 -60.53%
    Sept. 30, 2012 -53.75%
    June 30, 2012 -61.58%
    March 31, 2012 -76.00%
    Dec. 31, 2011 -89.81%
    Sept. 30, 2011 -153.3%
    June 30, 2011 -144.4%
    March 31, 2011 -271.1%
    Dec. 31, 2010 -309.1%
    Sept. 30, 2010 -617.4%
    June 30, 2010 -647.5%
    March 31, 2010 -343.1%
    Dec. 31, 2009 -189.4%
    Sept. 30, 2009 16.67%
    June 30, 2009 43.15%
    March 31, 2009 -21.95%
       
    Dec. 31, 2008 -119.4%
    Sept. 30, 2008 -165.3%
    June 30, 2008 -162.3%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    DVAX Return on Equity Benchmarks

    Companies
    GlaxoSmithKline 60.64%
    Anika Therapeutics 12.32%
    Array BioPharma

    DVAX Return on Equity Rankings

    Overall 46th percentile
    4253 of 8009
    Sector 44th percentile
    379 of 687 in Healthcare
    Industry 62nd percentile
    93 of 248 in Biotechnology

    DVAX Return on Equity Range, Past 5 Years

    Minimum -647.5% Jun 2010
    Maximum 43.15% Jun 2009
    Average -174.5%